A 2018 review of sixteen reports of cannabis-based mostly medicines for neuropathic soreness, most of which analyzed a cannabinoid preparation named nabiximols (model name Sativex; a mouth spray made up of equally THC and CBD which is authorized in some nations although not in the United States)